Remove 2024 Remove Diabetes Remove Private Practice Remove Provider
article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

In our third segment, we explore Amy Linskys study that examined the effect of patient-directed educational materials on clinician deprescribing of potentially low-benefit or high-risk medications, such as proton pump inhibitors, high-dose gabapentin, or risky diabetes medications. Eric 16:06 And people knew from an ethical standpoint.

article thumbnail

Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025

ABIM

Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025. The following is a summary of the spring meeting.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nurse Practitioners Critical in Treating Older Adults as Ranks of Geriatricians Shrink

Physician's Weekly

Ellen had been diagnosed with vascular dementia, peripheral vascular disease, and Type 2 diabetes. According to a 2024 survey , of the roughly 431,000 licensed nurse practitioners, 15% are, like Johnson, certified to treat older adults. “We step into places where other providers may not, and geriatrics is a prime example of that.”

article thumbnail

Allowing Patients to Die: Louise Aronson and Bill Andereck

GeriPal

Louise 05:02 Yes, well, I don’t know about 2024, but in 2023, yes, it could happen. It was a patient that I had taken care of, actually, as a resident, who followed me into my growing private practice. He was a terrible diabetic. And it’s not the same, but it does provide information.